v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Paid-in capital
Accumulated deflicit
Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2023 $ 11,288     $ 275,717 $ (264,417) $ (12)
Beginning balance (in shares) at Dec. 31, 2023   2,474,159 351,037      
Net loss (3,057)       (3,057)  
Vesting of restricted stock awards (in shares)   71,763        
Share-based compensation expense related to issuance of stock options and restricted stock awards 625     625    
Foreign currency translation adjustment (6)         (6)
Release of foreign currency translation adjustment upon liquidation of a subsidiary         (18) $ 18
Ending balance at Dec. 31, 2024 $ 8,850     276,342 (267,492)  
Ending balance (in shares) at Dec. 31, 2024 2,545,922 2,545,922 351,037      
Issuance of common stock - private placement, net of issuance cost (in share)   499,998        
Issuance of common stock - private placement, net of issuance cost $ 1,245     1,245    
Net loss (1,429)       (1,429)  
Vesting of restricted stock awards (in shares)   15,024        
Share-based compensation expense related to issuance of stock options and restricted stock awards 114     114    
Ending balance at Mar. 31, 2025 8,780     277,701 (268,921)  
Ending balance (in shares) at Mar. 31, 2025   3,060,944 351,037      
Beginning balance at Dec. 31, 2024 $ 8,850     276,342 (267,492)  
Beginning balance (in shares) at Dec. 31, 2024 2,545,922 2,545,922 351,037      
Issuance of common stock - private placement, net of issuance cost (in share)   499,998        
Issuance of common stock - private placement, net of issuance cost $ 1,245     1,245    
Issuance of common stock - ATM (in shares)   715,220        
Issuance of common stock - ATM 2,077     2,077    
Net loss (3,528)       (3,528)  
Vesting of restricted stock awards (in shares)   60,096        
Share-based compensation expense related to issuance of stock options and restricted stock awards 441     441    
Foreign currency translation adjustment 0          
Ending balance at Dec. 31, 2025 $ 9,085     280,105 (271,020)  
Ending balance (in shares) at Dec. 31, 2025 3,821,236 3,821,236 351,037      
Issuance of common stock - ATM (in shares)   405,000        
Issuance of common stock - ATM $ 825     825    
Net loss (3,177)       (3,177)  
Vesting of restricted stock awards (in shares)   15,024        
Share-based compensation expense related to issuance of stock options and restricted stock awards 58     58    
Ending balance at Mar. 31, 2026 $ 6,791     $ 280,988 $ (274,197)  
Ending balance (in shares) at Mar. 31, 2026 4,241,260 4,241,260 351,037